Pluristem Therapeutics Company
A biotechnology company using placental mesenchymal stem cells to develop cell therapies for medical conditions such as inflammation, ischemia, hematological disorders, and radiation.
(Reupload).jpg)
Technology:
SpaceTech
Industry:
Cell Therapy
Headquarters:
Haifa, Hefa, Israel
Founded Date:
2003
Employees Number:
5001-10000
Funding Status:
IPO
Investors Number:
2
Total Funding:
162494975
Estimated Revenue:
Less than $1M
Last Funding Date:
2021-02-02
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership